By Kilian Kobl - Project Manager at Ypso-Facto Current oligo manufacturing processes are still somewhat larger scale versions of the initial processes conceived in the lab. Oftentimes, during development of an API, the choice of speed had to be made at the expense of conceiving a process that produces...
The need to increase efficiency and productivity is driving adoption. The biopharmaceutical industry is faced with the challenge of increasing efficiency and productivity to get needed medicines to patients more quickly and cost-effectively. Greater productivity and process efficiency are also...
Courant 2022, Ypso-Facto va lancer une première version de sa suite logicielle Ypso-Proxima. Conçue selon une approche métier, elle a pour objectif d'aider les acteurs de la chimie fine et de la biotech à développer des procédés plus optimisés, grâce à l'apport d'outils numériques. L'enjeu...
Did you know that ... In addition to maximizes the value of experimental data and makes predictive simulation a game changer , Ypso-Ionic software can help you prepare your buffers in two clicks ! Select your raw materials Set-up your pH, concentration...
Tired of working with Excel spreadsheets? With multiple and complex software tools limiting your efficiency? What if you could have a single solution to capture your data and run predictive simulation? We have good news for you: Ypso-Ionic , the innovative software for designing chromatographic...
Do you work with mineral ions? With organic buffers? With proteins, peptides, or oligonucleotides whose retention behaviour is dramatically impacted by their charge? Ypso-Ionic® is a software solution for designing chromatographic processes . It offers the...
This article is based on a real industrial purification process by Fareva and highlights the power of mechanistic modeling for process development: Our client needed to change a raw material to secure his supply chain. From a process point of view, it was supposed to be seamless. However, a...
La crise actuelle rappelle à l’Europe (et sans doute à l’Amérique du Nord) les limites de la délocalisation de la production. C’est le cas pour de nombreux produits, incluant bon nombre d’ingrédients pharmaceutiques actifs (API) et de médicaments en général. Cela ouvre la possibilité...
The current crisis has highlighted the dependence of European and, indeed, North American countries on delocalised production. This is the case for many goods, including APIs and drugs in general. The opportunity is now there for European CDMOs to win additional business, but effort and adaptation...
Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.